Hallmarks of denervation in human patients. (A) Schematic representation of A-type lamin proteins. The position of the different mutations studied is indicated along the length of the protein. (B) Muscle biopsies from AD-EDMD, BMD, and CMS patients as well as normal volunteer (NV) were stained with DAPI (blue), α2-laminin antibody (green), and acetylated-histone H3-lysine 9 (K9) antibody (red). Atrophic muscle fibers (asterisks) showed a very high level of acetylation and no grouping of atrophic fibers. Muscle fibers of normal size occasionally showed hyperacetylated nuclei in AD-EDMD muscles. In contrast, hyperacetylated nuclei were only observed in nonmuscle interstitial cells in NV muscles. Although many centrally located nuclei could be observed in BMD muscles (arrowheads), most nuclei were in a subsarcolemmal position in AD-EDMD and CMS patients and in NV muscles. Bars, 30 μm. (C) Expression levels of CHRNG, CHRNA, MYOG, MYOD1, and FBXO32 were evaluated by quantitative RT-PCR on human biopsies. Patients affected by AD-EDMD were compared with patients affected by LGMD1B, FLPD-DCM-CD, ALS, CMS, BMD, and NV. Compared with NV, EDMD patients showed high, though similar to denervation-related diseases (ALS and CMS), levels of CHRNG, CHRNA, MYOG, and FBXO32. In contrast, expression levels of patients affected by the nondenervation-related disease BMD were similar to NV. Patients affected by other laminopathies (LGMD1B and FPLD-DCM-CD) showed low, though similar to normal volunteers, levels of CHRNG, CHRNA, and MYOG. All patients affected by neuromuscular diseases (ALS, CMS, EDMD, LGMD1B, and BMD) showed a high level of MYOD1 compared with NV but this could be caused by two independent mechanisms: misregulation in the muscle fibers (ALS, CMS, and potentially EDMD) and/or regeneration by the activated satellite cells (BMD). All gene expression levels were normalized to the GAPDH expression level. Values provided for each patient are means ± SD from at least three independent experiments. Broken lines indicate mean values of a group of patients.